CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in ENTA — Enanta Pharmaceuticals Inc
CIK 884546
SAN FRANCISCO, CA
Position in ENTA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,390,781
+$665,298 QoQ
Shares Held
301,151
+2.1% QoQ
Ownership
1.03%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 122 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. ENTA ranks #151 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in ENTA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,390,781 | 301,151 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,725,483 | 294,971 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,447,889 | 218,636 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,993,567 | 166,547 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,244,731 | 164,647 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $882,101 | 159,801 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $890,255 | 154,827 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,682,443 | 162,398 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,127,689 | 164,047 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,811,060 | 161,000 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,386,384 | 147,331 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,749,467 | 156,622 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,245,459 | 151,657 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $6,007,685 | 148,558 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,786,802 | 145,890 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $7,371,090 | 142,107 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,345,099 | 134,231 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $9,689,448 | 136,126 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $9,666,287 | 129,263 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $7,257,250 | 127,746 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $5,577,431 | 126,731 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,147,244 | 124,640 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $5,082,817 | 120,732 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $5,398,835 | 117,930 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $5,766,919 | 114,856 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $5,530,782 | 107,540 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||